Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Claritas Investors Facebook Page

<< Previous

Bullboard Posts

Next >>

Comment by PTBaileyon May 02, 2021 12:28pm

149 Views

Post# 33110735

RE:RE:Claritas Investors Facebook Page

Red~One wrote: I've heard that site is heavy duty pump machine and don't like to be doubted ?

Shouldn't believe every you hear. I use it and don't think that is accurate unless being optimistic about a stock you are invested in is being a pumper, then guilty as charged.

Think there is a big difference between pumping a stock and expressing hope and optimism while at thte same time addressing unfactual bashing, which isn't the same as doubting. We all have doubts, but I don't express them in a way that hurts the stock I want to succeed.

<< Previous

Bullboard Posts

Next >>

These cold weather stocks are looking to heat up for winter